SCHEMBL4956

SCHEMBL4956

[CH2]C1NCCS1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL213131 0.67 MAPT (0.38)
SCHEMBL3618802 0.65
SCHEMBL1418135 0.62
SCHEMBL28822444 0.62
SCHEMBL10352122 0.62
SCHEMBL6569259 0.62
SCHEMBL17533005 0.62
SCHEMBL4957 0.62
SCHEMBL5080954 0.62
SCHEMBL14848282 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 527 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113121393-A Aromatic amide compound and application thereof in medicines 广东东阳光药业有限公司 2021-07-16 CN claimed
WO-2021136326-A1 ARYL AMIDE COMPOUND AND APPLICATION THEREOF IN MEDICINE 广东东阳光药业有限公司 2021-07-08 WO claimed
EP-2150544-B1 MAPK/ERK KINASE INHIBITORS TAKEDA PHARMACEUTICAL (JP) 2016-01-13 EP claimed
EP-2590981-B1 NOVEL HOMOPIPERAZINE DERIVATIVES AS PROTEIN TYROSINE KINASE INHIBITORS AND PHARMACEUTICAL USE THEREOF LEO PHARMA AS (DK) 2014-09-03 EP claimed
US-8673890-B2 2,3-dihydro-1H-isoindol-1-imine derivatives useful as thrombin PAR-1 receptor antagonist JANSSEN PHARMACEUTICA NV (BE) 2014-03-18 US claimed
CN-102985425-A Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof LEO PHARMA AS 2013-03-20 CN claimed
CN-102718703-A Dimethyl-containing arylurea derivative with dual GK/PPAR agonist activities INST MATERIA MEDICA CAMS 2012-10-10 CN claimed
CN-102718727-A Arylurea derivative with dual GK/PPAR agonist activities INST MATERIA MEDICA CAMS 2012-10-10 CN claimed
EP-2318363-A1 HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS Nuevolution A/S (DK) 2011-05-11 EP claimed
US-20110105490-A1 2,3-DIHYDRO-1H-ISOINDOL-1-IMINE DERIVATIVES USEFUL AS THROMBIN PAR-1 RECEPTOR ANTAGONIST JANSSEN PHARMACEUTICA NV (BE) 2011-05-05 US claimed
WO-2008079814-A2 MAPK/ERK KINASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-07-03 WO claimed
US-20080125437-A1 MAPK/ERK KINASE INHIBITORS TAKEDA SAN DIEGO, INC. 2008-05-29 US claimed
WO-2008055236-A2 MAPK/ERK KINASE INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-05-08 WO claimed
EP-1003775-B1 HEPATITIS C INHIBITOR PEPTIDES BOEHRINGER INGELHEIM CA LTD (CA) 2005-03-16 EP claimed
US-6767991-B1 PEPTIDES AND ANALOGS THEREOF; VIRAL PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH PEPTIDES AND RIBAVIRIN BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 2004-07-27 US claimed
CN-1134411-C Bicyclic amino derivatives and PGDZ antagonist containing same C&C��ҩ�о��� 2004-01-14 CN claimed
EP-1003775-A2 HEPATITIS C INHIBITOR PEPTIDES BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 2000-05-31 EP claimed
WO-1999007733-A2 HEPATITIS C INHIBITOR PEPTIDES BOEHRINGER INGELHEIM (CANADA) LTD. (CA) 1999-02-18 WO claimed
CN-1193315-A Bicyclic amino derivatives and PGDZ antagonist containing same SHIONOGI PHARMACEUTIC K K (JP) 1998-09-16 CN claimed
EP-0473387-A2 Anti-fungal triazole derivatives, their preparation and uses Sankyo Company Limited (JP) 1992-03-04 EP claimed